These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17495861)

  • 1. A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure.
    Negishi K; Noiri E; Sugaya T; Li S; Megyesi J; Nagothu K; Portilla D
    Kidney Int; 2007 Aug; 72(3):348-58. PubMed ID: 17495861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal L-type fatty acid-binding protein mediates the bezafibrate reduction of cisplatin-induced acute kidney injury.
    Negishi K; Noiri E; Maeda R; Portilla D; Sugaya T; Fujita T
    Kidney Int; 2008 Jun; 73(12):1374-84. PubMed ID: 18368030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrate prevents cisplatin-induced proximal tubule cell death.
    Nagothu KK; Bhatt R; Kaushal GP; Portilla D
    Kidney Int; 2005 Dec; 68(6):2680-93. PubMed ID: 16316343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolomic study of cisplatin-induced nephrotoxicity.
    Portilla D; Li S; Nagothu KK; Megyesi J; Kaissling B; Schnackenberg L; Safirstein RL; Beger RD
    Kidney Int; 2006 Jun; 69(12):2194-204. PubMed ID: 16672910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PPAR-alpha ligand ameliorates acute renal failure by reducing cisplatin-induced increased expression of renal endonuclease G.
    Li S; Basnakian A; Bhatt R; Megyesi J; Gokden N; Shah SV; Portilla D
    Am J Physiol Renal Physiol; 2004 Nov; 287(5):F990-8. PubMed ID: 15280156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced kidney lipoprotein lipase and renal tubule triglyceride accumulation in cisplatin-mediated acute kidney injury.
    Li S; Nagothu K; Ranganathan G; Ali SM; Shank B; Gokden N; Ayyadevara S; Megyesi J; Olivecrona G; Chugh SS; Kersten S; Portilla D
    Am J Physiol Renal Physiol; 2012 Aug; 303(3):F437-48. PubMed ID: 22622461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity.
    Li S; Wu P; Yarlagadda P; Vadjunec NM; Proia AD; Harris RA; Portilla D
    Am J Physiol Renal Physiol; 2004 Mar; 286(3):F572-80. PubMed ID: 14612380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of PPARalpha and its coactivator PGC-1 in cisplatin-induced acute renal failure.
    Portilla D; Dai G; McClure T; Bates L; Kurten R; Megyesi J; Price P; Li S
    Kidney Int; 2002 Oct; 62(4):1208-18. PubMed ID: 12234291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity.
    Matsui K; Kamijo-Ikemorif A; Sugaya T; Yasuda T; Kimura K
    Am J Pathol; 2011 Mar; 178(3):1021-32. PubMed ID: 21356355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of diabetic tubulointerstitial damage in liver-type fatty acid-binding protein transgenic mice.
    Kamijo-Ikemori A; Sugaya T; Sekizuka A; Hirata K; Kimura K
    Nephrol Dial Transplant; 2009 Mar; 24(3):788-800. PubMed ID: 18854419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstitial renal fibrosis due to multiple cisplatin treatments is ameliorated by semicarbazide-sensitive amine oxidase inhibition.
    Katagiri D; Hamasaki Y; Doi K; Negishi K; Sugaya T; Nangaku M; Noiri E
    Kidney Int; 2016 Feb; 89(2):374-85. PubMed ID: 26535996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-type fatty acid-binding protein attenuates renal injury induced by unilateral ureteral obstruction.
    Kamijo-Ikemori A; Sugaya T; Obama A; Hiroi J; Miura H; Watanabe M; Kumai T; Ohtani-Kaneko R; Hirata K; Kimura K
    Am J Pathol; 2006 Oct; 169(4):1107-17. PubMed ID: 17003471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective effects of tubular liver-type fatty acid-binding protein against glomerular damage in murine IgA nephropathy.
    Zuo N; Suzuki Y; Sugaya T; Osaki K; Kanaguchi Y; Wang L; Tomino Y
    Nephrol Dial Transplant; 2011 Jul; 26(7):2127-37. PubMed ID: 21109611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-type fatty acid binding protein transgenic mouse as a novel tool to explore cytotoxicity to renal proximal tubules.
    Nakamura K; Ito K; Kato Y; Sugaya T; Kubo Y; Tsuji A
    Drug Metab Pharmacokinet; 2008; 23(4):271-8. PubMed ID: 18762714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory effect of fibrate protects from cisplatin-induced ARF.
    Li S; Gokden N; Okusa MD; Bhatt R; Portilla D
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F469-80. PubMed ID: 15814532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Urinary L-type fatty acid binding protein (L-FABP) as a new urinary biomarker promulgated by the Ministry of Health, Labour and Welfare in Japan].
    Kamijo-Ikemori A; Ichikawa D; Matsui K; Yokoyama T; Sugaya T; Kimura K
    Rinsho Byori; 2013 Jul; 61(7):635-40. PubMed ID: 24205707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variation of liver-type fatty acid binding protein content in the human hepatoma cell line HepG2 by peroxisome proliferators and antisense RNA affects the rate of fatty acid uptake.
    Wolfrum C; Buhlmann C; Rolf B; Börchers T; Spener F
    Biochim Biophys Acta; 1999 Feb; 1437(2):194-201. PubMed ID: 10064902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of L-type fatty acid-binding protein (L-FABP) in proximal tubular cells against glomerular injury in anti-GBM antibody-mediated glomerulonephritis.
    Kanaguchi Y; Suzuki Y; Osaki K; Sugaya T; Horikoshi S; Tomino Y
    Nephrol Dial Transplant; 2011 Nov; 26(11):3465-73. PubMed ID: 21525165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Localization of a portion of the liver isoform of fatty-acid-binding protein (L-FABP) to peroxisomes.
    Antonenkov VD; Sormunen RT; Ohlmeier S; Amery L; Fransen M; Mannaerts GP; Hiltunen JK
    Biochem J; 2006 Mar; 394(Pt 2):475-84. PubMed ID: 16262600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of human liver type fatty acid binding protein in kidney disease clarified using hL-FABP chromosomal transgenic mice.
    Kamijo-Ikemori A; Sugaya T; Matsui K; Yokoyama T; Kimura K
    Nephrology (Carlton); 2011 Aug; 16(6):539-44. PubMed ID: 21504508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.